[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-fushuliang":3},{"head":4,"company":38,"invest":43,"children":44,"shops":74,"category":75,"sameIndustry":5,"rid":6},{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"brandId":6,"brandLogo":7,"brandImage":5,"brandName":8,"webName":9,"balias":5,"enterId":10,"mainindustry":11,"industry":5,"brandType":5,"brandHonor":5,"brandTel":12,"establishdate":5,"brandBirth":5,"cityarea":5,"brandWebsite":5,"brandSobp":5,"brandVisit":5,"totalVisits":13,"status":14,"isDeleted":14,"comment":5,"remark":5,"logoExistStatus":15,"imageExistStatus":15,"industryId":5,"industryRanking":5,"score":5,"enterName":16,"mallShopList":17,"brandSummary":18,"likes":5,"unlikes":5,"follow":5,"pagetitle":19,"pagekeywords":20,"pagedesc":21,"brandContent":22,"province":5,"city":5,"area":5,"detailaddress":23,"unifiedscc":24,"enterType":25,"enterLegalperson":26,"enterStablishdate":27,"regauthority":28,"licenseValidity":29,"approvaldate":30,"regcapital":31,"incapital":32,"businessscope":33,"ownBrand":5,"enterTelphone":34,"enterWebsite":35,"business":36,"enterQq":5,"enterMail":37,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"regtrademark":5},null,"4089083","\u002Fprofile\u002Fupload\u002F2022\u002F10\u002F20\u002F6ac03d8191a617887ad5868bd473bddc.gif","辅舒良","fushuliang",5811,9659,"400-991-1165",596,0,"1","中美天津史克制药有限公司",[],"世界知名鼻用喷雾剂品牌，是葛兰素史克集团（GSK）在呼吸健康领域的重要产品之一，其核心成分为丙酸氟替卡松，凭借快速起效和持久舒缓的特点而享誉全球市场。辅舒良不仅体现了公司在医药研发上的前沿实力，也为改善患者生活质量提供了专业的产品解决方案。","辅舒良简介-辅舒良鼻炎喷剂-中国品牌之家","辅舒良品牌介绍,中美天津史克制药有限公司,辅舒良联系电话,辅舒良鼻炎喷剂,辅舒良","辅舒良品牌简介，中国品牌之家为你介绍中美天津史克制药有限公司旗下辅舒良品牌信息，包括品牌介绍、联系方式、主营产品、最新评论、点赞数量等，告诉你辅舒良鼻炎喷剂怎么样，致力于帮助你了解辅舒良真实有效的品牌相关信息。","辅舒良（FLIXONASE®）鼻喷雾剂备受信任，值得您信赖的药物。可在各大药房购买，无需医生处方。适用于预防和治疗季节性过敏性鼻炎（包括枯草热）和常年性过敏性鼻炎。辅舒良鼻喷雾剂，每天使用一次药效可持续24小时，帮你有效缓解鼻塞、鼻痒、流鼻涕、打喷嚏、过敏性鼻炎不适症状。\n\n辅舒良隶属于葛兰素史克公司，目前在全球多个国家和地区均有销售。葛兰素史克是一家以研发为基础的药品和保健品供应商，由葛兰素威康和史克必成于2000年合并而成，在抗感染、中枢神经系统、呼吸和胃肠道、代谢等医疗领域拥有较高的知名度和美誉度。","天津市东丽区程林庄工业区","9112011060055017XM","有限责任公司(外商投资、非独资)","顾海英","1984-09-23","天津市市场监督管理委员会","1984-09-23 至 2025-06-30","2024-12-30","2,994万(美元)","-","许可项目：药品生产（除中药饮片的蒸、炒、炙、煅等炮制技术的应用及中成药保密处方产品的生产）；药品批发；药品零售；药品委托生产；药品进出口；药品类易制毒化学品销售；第二类医疗器械生产；药品互联网信息服务（除电信公司业务）；食品销售；食品互联网销售；餐饮服务；消毒剂生产（不含危险化学品）；第三类医疗器械经营。（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）一般项目：第二类医疗器械销售；货物进出口；食品进出口；化妆品批发；化妆品零售；消毒剂销售（不含危险化学品）；日用百货销售；体育用品及器材批发；体育用品及器材零售；户外用品销售；互联网销售（除销售需要许可的商品）；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广（除人体干细胞、基因诊断与治疗技术开发和应用）；市场营销策划；健康咨询服务（不含诊疗服务）；医学研究和试验发展（除人体干细胞、基因诊断与治疗技术开发和应用）。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）（不得投资《外商投资准入负面清单》中禁止外商投资的领域）","022-24700888","42.81.136.168","医药制造业","weigao.x.huo@haleon.com",{"enterId":39,"enterName":16,"province":5,"city":5,"area":5,"detailaddress":23,"unifiedscc":24,"enterType":25,"enterLegalperson":26,"enterStablishdate":27,"regauthority":28,"licenseValidity":29,"approvaldate":30,"regcapital":31,"incapital":32,"businessscope":33,"ownBrand":5,"enterTelphone":34,"enterWebsite":35,"business":36,"performance":40,"socialSecurity":41,"registrationNumber":42,"enterQq":5,"enterMail":37,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"status":14,"regtrademark":5,"remark":5},"5811","开业","924人","120000400041424",{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"id":5,"brandId":5,"brandName":5,"busmodel":5,"franchiseFund":5,"totalStores":5,"devmodel":5,"franchiseIndustry":5,"investmenttel":5,"suitablePeople":5,"state":5},[45,53,64],{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"brandId":39,"brandLogo":46,"brandImage":5,"brandName":47,"webName":48,"balias":5,"enterId":10,"mainindustry":49,"industry":5,"brandType":5,"brandHonor":5,"brandTel":12,"establishdate":5,"brandBirth":50,"cityarea":5,"brandWebsite":5,"brandSobp":5,"brandVisit":5,"totalVisits":51,"status":14,"isDeleted":14,"comment":5,"remark":5,"logoExistStatus":15,"imageExistStatus":15,"industryId":5,"industryRanking":5,"score":5,"enterName":16,"mallShopList":5,"brandSummary":52,"province":5,"city":5,"area":5,"detailaddress":23,"unifiedscc":24,"enterType":25,"enterLegalperson":26,"enterStablishdate":27,"regauthority":28,"licenseValidity":29,"approvaldate":30,"regcapital":31,"incapital":32,"businessscope":33,"ownBrand":5,"enterTelphone":34,"enterWebsite":35,"business":36,"performance":40,"socialSecurity":41,"registrationNumber":42,"enterQq":5,"enterMail":37,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"regtrademark":5},"\u002Fprofile\u002Fupload\u002F2025\u002F01\u002F25\u002F0603be4eea2fc56d8f5f83ea4bce1fb0.gif","新康泰克","xinkangtaike",1389,"美国",923,"国内知名感冒药品牌，由中外合资企业——中美史克制药集团出品，致力于呼吸健康用药研发、生产、销售的现代化企业。新康泰克凭借前沿的配方设计和给药技术，相继开发出新康泰克氨酚咖那敏片、新康泰克通气鼻贴、新康泰克咳嗽药、新康泰克愈美片等多个品类，产品已广销于全国多个省市的大型连锁医药零售网点和医疗服务机构。",{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"brandId":54,"brandLogo":55,"brandImage":5,"brandName":56,"webName":57,"balias":5,"enterId":10,"mainindustry":58,"industry":5,"brandType":5,"brandHonor":5,"brandTel":59,"establishdate":60,"brandBirth":61,"cityarea":5,"brandWebsite":5,"brandSobp":5,"brandVisit":5,"totalVisits":62,"status":14,"isDeleted":14,"comment":5,"remark":5,"logoExistStatus":15,"imageExistStatus":15,"industryId":5,"industryRanking":5,"score":5,"enterName":16,"mallShopList":5,"brandSummary":63,"province":5,"city":5,"area":5,"detailaddress":23,"unifiedscc":24,"enterType":25,"enterLegalperson":26,"enterStablishdate":27,"regauthority":28,"licenseValidity":29,"approvaldate":30,"regcapital":31,"incapital":32,"businessscope":33,"ownBrand":5,"enterTelphone":34,"enterWebsite":35,"business":36,"performance":40,"socialSecurity":41,"registrationNumber":42,"enterQq":5,"enterMail":37,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"regtrademark":5},"18918","\u002Fprofile\u002Fupload\u002F2025\u002F01\u002F25\u002F48d746dd04e4499989c3678eb2d73f84.gif","百多邦","baiduobang",2409,"400-9911-165","1985年","英国",528,"百多邦®是中美史克旗下皮肤外用抗细菌感染的品牌。1985年在英国上市，于1993年由中美史克引入中国，由于良好的用药记录，在2006年申请成为非处方药（OTC）上市。",{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"brandId":65,"brandLogo":66,"brandImage":5,"brandName":67,"webName":68,"balias":5,"enterId":10,"mainindustry":69,"industry":5,"brandType":5,"brandHonor":5,"brandTel":5,"establishdate":70,"brandBirth":71,"cityarea":5,"brandWebsite":5,"brandSobp":5,"brandVisit":5,"totalVisits":72,"status":14,"isDeleted":14,"comment":5,"remark":5,"logoExistStatus":15,"imageExistStatus":15,"industryId":5,"industryRanking":5,"score":5,"enterName":16,"mallShopList":5,"brandSummary":73,"province":5,"city":5,"area":5,"detailaddress":23,"unifiedscc":24,"enterType":25,"enterLegalperson":26,"enterStablishdate":27,"regauthority":28,"licenseValidity":29,"approvaldate":30,"regcapital":31,"incapital":32,"businessscope":33,"ownBrand":5,"enterTelphone":34,"enterWebsite":35,"business":36,"performance":40,"socialSecurity":41,"registrationNumber":42,"enterQq":5,"enterMail":37,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"regtrademark":5},"19257","\u002Fprofile\u002Fupload\u002F2025\u002F01\u002F25\u002F39acb41ba9e732239f7b05f35141b111.gif","中美史克","zhongmeishike",10118,"1987年","天津市",896,"中美天津史克制药有限公司是GSK和国内大型药厂天津中新药业集团股份有限公司和天津市医药集团有限公司共同投资设立的公司。作为较早在华设立的外商合资药厂之一，中美史克早在1987年便在中国生根。",[],[76],{"createTime":77,"updateTime":78,"createBy":5,"updateBy":5,"industryId":79,"webId":5,"industryName":80,"industryAlias":5,"industryIcon":5,"industryTrans":81,"pageTitle":82,"pageDesc":83,"pageKeywords":84,"mainTitle":85,"pageSubtitle":86,"indSummary":87,"industryLevel":88,"parentId":89,"parentName":5,"sortOrder":90,"status":14,"classifyVisit":5,"totalVisits":91,"searchName":5,"starLevel":5,"limit":5},"2000-01-01 00:00:00","2026-06-16 16:50:00","9659","鼻炎喷剂","\u002Fprofile\u002Fupload\u002F2023\u002F11\u002F08\u002F1b04a8fe37d4fce1b76de2894abf5a1f.png","十大鼻炎喷剂品牌-鼻炎喷雾剂哪个牌子好-ZGALL品牌榜","2026年鼻炎喷剂行业十大品牌权威发布！鼻炎喷剂排行榜前十名品牌有辅舒良、科赴、默沙东、仙琚、大佛药业、诺通、民生药业、新康泰克、星银、京卫。鼻炎喷剂10大品牌由品牌中国重磅推出，旨在呈现行业领域标杆品牌，展现行业优秀企业实力，帮助你了解鼻炎喷剂哪个牌子好。","鼻炎喷雾剂哪个好,鼻喷雾剂十大排名,鼻炎喷剂哪个牌子好,过敏性鼻炎喷剂十大排行榜,鼻炎喷雾剂哪个牌子好","鼻炎喷剂品牌排行榜","2026鼻炎喷剂品牌排行榜，鼻炎喷雾-鼻喷雾剂品牌排行，鼻炎喷剂哪个品牌好","鼻炎喷剂什么牌子好？品牌TOP榜权威发布2026年鼻炎喷剂十大品牌名录；居前十的有：FLIXONASE辅舒良、雷诺考特、NASONEX内舒拿、逸青、达芬霖、诺通、民生药业、新康泰克、星瑞克、倍可适等，【行业品牌名录】基于大数据与人工智能技术，整合300+国际权威榜单及企业申报数据，通过算法分析市场占有率、创新力等12项指标，并解析超百万条舆情信息，采用加权模型（算法60%+专家30%+用户10%）生成动态排名。数据月度更新，申报需通过ISO认证审核，排名不分先后，仅供参考。",3,1411,99,681]